NCT01687374View on ClinicalTrials.gov

Parathyroid Hormone for the Treatment of Humerus Fractures

PHASE4UnknownINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2013

Conditions
Shoulder Fractures
Interventions
DRUG

1-84 parathyroid hormone

100 micrograms of 1-84 parathyroid hormone daily for 8 weeks, subcutaneous injection.

DRUG

Placebo

Saline injection daily for 8 weeks.

Trial Locations (1)

2650

RECRUITING

Hvidovre Hospital, Hvidovre

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Hvidovre University Hospital

OTHER